Novo obesity drug seen with 43 percent chance of approval - Reuters UK

COPENHAGEN (Reuters) - Danish group Novo Nordisk's diabetes drug Victoza has a 43 percent chance of being approved as an obesity treatment in the United States, according to a Reuters poll which found Danish bank analysts had the highest expectations.

Can a shot make you skinny? - kptv.com

I love to fish in Montana and Idaho," the Tigard woman said. Managing her type-two diabetes was getting in the way of Walker's active lifestyle, but that was before she started taking Victoza, a shot designed to help diabetics manage their blood sugar.

Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover - Bloomberg

Novo Nordisk is the world’s biggest insulin maker, and its once-daily GLP-1 drug, Victoza, had sales of 5.99 billion kroner ($1 billion) last year. In November, Glaxo released some data from Harmony 7 that showed it failed to help diabetics ...

Novo’s Insulin Pill Quest is Holy Grail for Diabetics - Businessweek

First-quarter earnings missed estimates, hurt by slower-than-expected sales of Victoza, also a medicine for diabetics, and NovoSeven, a hemophilia treatment. When swallowed, insulin embarks on a journey that takes it through the stomach and the ...

FDA Clears Novo Nordisk’s Levemir for Diabetic Children Aged Two Years and Over - Genetic Engineering News

The firm’s diabetes franchise, which includes Victoza®, modern insulins (including Levmir, NovoRapid® and NovoMix®), human insulins, oral antidiabetics, and protein-related products, achieved Q1 2012 sales of nearly DKK 13.9 billion (nearly $2.4 ...

Bydureon FDA Approval: Physician Opinion - new market research report - Transworld News

This survey shows broad enthusiasm for the drug among endocrinologists and PCPs, but initial excitement may wane as physicians fully weigh such factors as comparative efficacy with Novo Nordisk's Victoza (liraglutide), injection device size and convenience ...

Cooking With Paula Deen: A Look at the Difference Between Food Magazines - Huffington Post

Love and Best Dishes, y'all!" Although I question her industry ties and commercial interests - in the current issue of Cooking with Paula Deen she is the main face for Philadelphia Cream Cheese, Royal Caribbean, Victoza (a prescription diabetes drug ...

Paula Deen at the Crossroads: Punch Line or Role Model? - Huffington Post

Her timing for this announcement was clearly no accident as she also revealed that she is now a paid spokesperson for the Novo-Nordisk diabetes drug, Victoza. Ms. Deen, whose high-calorie recipes and super-sized portions have made her both a Food Network ...

Six Suitors Join Bristol-Myers in Considering a Bid for Amylin - Genetic Engineering News

That would put Sanofi behind Novartis’ Ideglira fixed-dose combination of Victoza and Degludec, for which data is likely to be published in July or August. Amylin would bring several key strategic positives and substantial operational ...

Diabetes Therapeutics Market to 2017 - pressreleasepoint.com

In addition, Novo Nordisk’s Victoza is expected to give tough competition to Merck’s Januvia and is expected to generate sales of $1.4 billion by 2014.  - Data and analysis on the diabetes therapeutics market in the leading geographies of the world ...